In a filing, Tango Therapeutics Inc revealed its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18 ’24. In the deal valued at $3.78 per share,10,000 shares were bought. As a result of this transaction, Rothenberg Mace now holds 31,250 shares worth roughly $0.1 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Rothenberg Mace bought 10,000 shares, generating $36,200 in total proceeds. Upon buying the shares at $3.62, the Director now owns 21,250 shares.
Before that, EcoR1 Capital, LLC sold 1,494,558 shares. Tango Therapeutics Inc shares valued at $4,896,023 were divested by the 10% Owner at a price of $3.28 per share. As a result of the transaction, EcoR1 Capital, LLC now holds 11,836,178 shares, worth roughly $37.99 million.
Jefferies initiated its Tango Therapeutics Inc [TNGX] rating to a Buy in a research note published on July 17, 2024; the price target was $19. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early April with a ‘”an Overweight”‘ rating. Piper Sandler began covering TNGX with “an Overweight” recommendation on February 12, 2024. B. Riley Securities started covering the stock on December 08, 2023. It rated TNGX as “a Buy”.
Price Performance Review of TNGX
On Monday, Tango Therapeutics Inc [NASDAQ:TNGX] saw its stock fall -5.17% to $3.21. Over the last five days, the stock has lost -17.48%. Tango Therapeutics Inc shares have fallen nearly -67.58% since the year began. Nevertheless, the stocks have fallen -62.46% over the past one year. While a 52-week high of $13.01 was reached on 01/25/24, a 52-week low of $2.70 was recorded on 11/11/24. SMA at 50 days reached $5.18, while 200 days put it at $7.91.
Levels Of Support And Resistance For TNGX Stock
The 24-hour chart illustrates a support level at 3.11, which if violated will result in even more drops to 3.02. On the upside, there is a resistance level at 3.40. A further resistance level may holdings at 3.60. The Relative Strength Index (RSI) on the 14-day chart is 32.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics %K at 6.82% indicates the stock is a buying.
How much short interest is there in Tango Therapeutics Inc?
A steep rise in short interest was recorded in Tango Therapeutics Inc stocks on 2024-11-15, dropping by -1.8 million shares to a total of 7.11 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 8.9 million shares. There was a decline of -25.27%, which implies that there is a negative sentiment for the stock.
